Literature DB >> 9334891

Effect of lecithinized-superoxide dismutase on the interstitial pneumonia model induced by bleomycin in mice.

C Yamazaki1, J Hoshino, Y Hori, T Sekiguchi, S Miyauchi, S Mizuno, K Horie.   

Abstract

Superoxide anion (O2-) acts as an exacerbation factor in interstitial pneumonia. Lecithinized-superoxide dismutase (PC-SOD), which is synthesized with a lecithin derivative bound covalently to recombinant human Cu,Zn-SOD, has a longer half-life in plasma and higher affinity to cell membranes than unmodified SOD. The effect of PC-SOD was evaluated using the bleomycin-induced interstitial pneumonia mouse model. Treatment with PC-SOD at 10 mg/kg significantly reduced the hydroxyproline content and fibrosis score. Namely, PC-SOD suppressed the progression of pulmonary fibrosis on the bleomycin-induced interstitial pneumonia mouse model. PC-SOD may be a potential drug for interstitial pneumonia therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334891     DOI: 10.1254/jjp.75.97

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  4 in total

Review 1.  Antioxidants as potential therapeutics for lung fibrosis.

Authors:  Brian J Day
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

Review 2.  The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

Authors:  Antje Moeller; Kjetil Ask; David Warburton; Jack Gauldie; Martin Kolb
Journal:  Int J Biochem Cell Biol       Date:  2007-08-30       Impact factor: 5.085

3.  Double-blind controlled trial of lecithinized superoxide dismutase in patients with idiopathic interstitial pneumonia - short term evaluation of safety and tolerability.

Authors:  Koichiro Kamio; Arata Azuma; Ken Ohta; Yukihiko Sugiyama; Toshihiro Nukiwa; Shoji Kudoh; Tohru Mizushima
Journal:  BMC Pulm Med       Date:  2014-05-17       Impact factor: 3.317

Review 4.  Role of redoximiRs in fibrogenesis.

Authors:  Marta Fierro-Fernández; Verónica Miguel; Santiago Lamas
Journal:  Redox Biol       Date:  2015-11-19       Impact factor: 11.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.